clinicaltrials.pharmaceutical-business-review.comClinical Trials Archives - Pharmaceutical Business review

-- Pharmaceutical Business review -- -- Pharmaceutical Business review is using cookies Continue Learn More Close ☰ Search × Home About Us Add Company Advertise with us Contact us Events Suplpiers News Clinical Trials Drug Discovery Packaging & Supply Chain Production & Sales Regulation Advertise With Us Advertise on our extensive network of industry websites and newsletters. Get the PBR newsletter Sign up to our free email to get all the latest PBR news. Home Drug Discovery Drug Discovery Research & Development Pre-clinical Studies Research & Development CBDepot Research & Development Pfizer acquires Amplyx Pharmaceuticals Research & Development Clinical Trials Clinical Trials Patient Enrollment Human Trials Patient Enrollment AM-Pharma enrols first patients in Covid-19 phase III trial Clinical Trials Patient Enrollment FSD Pharma doses first patient in phase 2 Covid-19 trial of FSD201 Clinical Trials Patient Enrollment Regulation Regulation Drug Filing Approvals Rejections Marketing Authorisation Patents Lawsuits Drug Filing Takeda submits New Drug Application for lanadelumab in Japan Drug Filing Approvals Haematology Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US Regulation Drug Filing Production & Sales Production & Sales Production & Sales Manufacturing Launches Recalls Marketing & Sales Manufacturing SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China Manufacturing Marketing & Sales Neurology Biogen and Bio-Thera Solutions announce commercialisation and license agreement for BAT1806 Manufacturing Osteoarthritis Packaging & Supply Chain Packaging & Supply Chain Packaging Cold Chain Distribution Storage Packaging Gerresheimer Packaging PCI Pharma announces bottling line expansion at Rockford site Packaging & Supply Chain Packaging Suppliers Suppliers A-Z Suppliers Products & Services Videos White Papers No data found Events -- Register Log In Clinical Trials 26 Apr 2021 Clinical Trials Study finds PARP inhibitors kill cancer cells with defect in PBRM1 gene By PBR Staff Writer A study, conducted by The Institute of Cancer Research, London (ICR) and Paris-based cancer research institute Gustave Roussy, identified that drugs known as PARP inhibitors kill cancer cells with a particular defect in the PBRM1 gene. 22 Apr 2021 Clinical Trials Claritas and CMAX Clinical sign agreement for Phase 1 R-107 clinical study By PBR Staff Writer Claritas Pharmaceuticals and CMAX Clinical Research have signed an agreement to conduct a Phase 1 clinical study of R-107. 06 Apr 2021 Clinical Trials Antengene announces China’s NMPA approval for IND application for ATG-019 clinical trial By PBR Staff Writer Antengene has announced that China’s National Medical Products Administration (NMPA) has given approval to investigational new drug (IND) application for Phase I clinical trials of ATG-019 (monotherapy or combined with niacin ER) in patients with advanced solid tumors or non-Hodgkin's lymphoma (NHL). 25 Mar 2021 Clinical Trials UCLA-led lab study identifies potential drug to treat SARS-CoV-2 virus By PBR Staff Writer A study led by the University of California, Los Angeles (UCLA) has identified a compound, berzosertib, which showed potential in treating SARS-CoV-2 virus which causes Covid-19. 17 Mar 2021 Human Trials Production & Sales Drug Delivery AstraZeneca to deliver 500,000 more doses of AZD7442 to US By PBR Staff Writer The UK’s Cambridge-based biopharma company AstraZeneca will be delivering 500,000 more doses of AZD7442 to the US after having modified an existing agreement with the US Government. 12 Mar 2021 Biotechnology Research & Development Clinical Trials NIAID grants $2.5m to 12 institutes for bacteriophage therapy research By PBR Staff Writer A branch of the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID) has granted $2.5m to 12 institutes across the world for bacteriophage therapy research. 18 Feb 2021 Clinical Trials GlaxoSmithKline and Vir Biotechnology to expand Covid-19 partnership By PBR Staff Writer GlaxoSmithKline has signed an agreement with Vir Biotechnology to expand their Covid-19 collaboration to advance new therapeutics for influenza and other respiratory viruses. 17 Feb 2021 Human Trials Infectious Disease Johnson & Johnson seeks EU approval for its COVID-19 vaccine By PBR Staff Writer Janssen-Cilag International, a subsidiary of Johnson & Johnson has submitted a conditional marketing authorisation application (cMAA) to the European Medicines Agency (EMA) for its investigational single-dose Janssen COVID-19 vaccine candidate. 15 Feb 2021 Clinical Trials Infectious Disease Oxford University commences trial on Covid-19 vaccine on children By PBR Staff Writer The University of Oxford, along with three partner sites in the UK, has commenced the first trial to evaluate the safety and immune responses in children and young adults of the ChAdOx1 nCoV-19 coronavirus vaccine. 10 Feb 2021 Human Trials Approvals Drug Manufacturing USFDA approves EUA for bamlanivimab-etesevimab combo to treat Covid-19 patients By vbandhakavi The U.S. Food and Drug Administration (FDA) has approved Emergency Use Authorization (EUA) for investigational bamlanivimab and etesevimab as a combination therapy for the treatment of mild to moderate Covid-19 patients. -- -- About Us Advertise with us Contact us PRIVACY POLICY TERMS AND CONDITIONS © PBR 2021. Part of Progressive Trade Media Ltd. Lost Password Back ⟶ Login Register Get new password Lost Password? Login Registration is disabled....